|
1
|
Zhang F, Xu Z, Wang K, Sun L, Liu G and
Han B: microRNA and gene networks in human laryngeal cancer. Exp
Ther Med. 10:2245–2252. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li W, Ma H and Sun J: microRNA-34a/c
function as tumor suppressors in Hep-2 laryngeal carcinoma cells
and may reduce GALNT7 expression. Mol Med Rep. 9:1293–1298. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li Y, Yan L, Zhang W, Wang H, Chen W, Hu N
and Ou H: miR-21 inhibitor suppresses proliferation and migration
of nasopharyngeal carcinoma cells through down-regulation of BCL2
expression. Int J Clin Exp Pathol. 7:3478–3487. 2014.PubMed/NCBI
|
|
4
|
Ren J, Zhu D, Liu M, Sun Y and Tian L:
Downregulation of miR-21 modulates Ras expression to promote
apoptosis and suppress invasion of Laryngeal squamous cell
carcinoma. Eur J Cancer. 46:3409–3416. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang N, Hui L, Wang Y, Yang H and Jiang X:
SOX2 promotes the migration and invasion of laryngeal cancer cells
by induction of MMP-2 via the PI3K/Akt/mTOR pathway. Oncol Rep.
31:2651–2659. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Starska K, Forma E, Jóźwiak P, Bryś M,
Lewy-Trenda I, Brzezińska-Błaszczyk E and Krześlak A: Gene and
protein expression of glucose transporter 1 and glucose transporter
3 in human laryngeal cancer-the relationship with regulatory
hypoxia-inducible factor-1α expression, tumor invasiveness, and
patient prognosis. Tumor Biol. 36:2309–2321. 2015. View Article : Google Scholar
|
|
7
|
Saito K, Inagaki K, Kamimoto T, Ito Y,
Sugita T, Nakajo S, Hirasawa A, Iwamaru A, Ishikura T, Hanaoka H,
et al: MicroRNA-196a is a putative diagnostic biomarker and
therapeutic target for laryngeal cancer. PLoS One. 8:e714802013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sun X, Liu B, Zhao XD, Wang LY and Ji WY:
MicroRNA-221 accelerates the proliferation of laryngeal cancer cell
line Hep-2 by suppressing Apaf-1. Oncol Rep. 33:1221–1226. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cimmino A, Calin GA, Fabbri M, Iorio MV,
Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M, et
al: miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl
Acad Sci USA. 102:pp. 13944–13949. 2005; View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jin YT, Kayser S, Kemp BL, Ordonez NG,
Tucker SL, Clayman GL, Goepfert H, Luna MA, Batsakis JG and
El-Naggar AK: The prognostic significance of the biomarkers
p21WAF1/CIP1, p53, and bcl-2 in laryngeal squamous cell carcinoma.
Cancer. 82:2159–2165. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Du J, Chen G, Vlantis A, Chan P, Tsang R
and van Hasselt C: Resistance to apoptosis of HPV 16-infected
laryngeal cancer cells is associated with decreased Bak and
increased Bcl-2 expression. Cancer Lett. 205:81–88. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gurlek U, Abakay CD, Ozkan L, Saraydaroglu
O, Kurt M and Cetintas SK: The evaluation of bcl-2 expression as a
prognostic marker in early stage laryngeal cancer. Tumori.
99:682–688. 2013.PubMed/NCBI
|
|
13
|
Zirnheld AL, Regalado EL, Shetty V,
Chertkow H, Schipper HM and Wang E: Target genes of circulating
miR-34c as plasma protein bio markers of Alzheimer's disease and
mild cognitive impairment. J Aging Sci. 5:e1252017.
|
|
14
|
Cao SE, Tian J, Chen S, Zhang X and Zhang
Y: Role of miR-34c in ketamine-induced neurotoxicity in neonatal
mice hippocampus. Cell Biol Int. 39:164–168. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang S, Yu M, Liu C, Wang L, Hu Y, Bai Y
and Hua J: MIR-34c regulates mouse embryonic stem cells
differentiation into male germ-like cells through RARg. Cell
Biochem Funct. 30:623–632. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang HX and Tang C: Galangin suppresses
human laryngeal carcinoma via modulation of caspase-3 and AKT
signaling pathways. Oncol Rep. 38:703–714. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang S, Li WS, Dong F, Sun HM, Wu B, Tan
J, Zou WJ and Zhou DS: KITLG is a novel target of miR-34c that is
associated with the inhibition of growth and invasion in colorectal
cancer cells. J Cell Mol Med. 18:2092–2102. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Valastyan S, Reinhardt F, Benaich N,
Calogrias D, Szász AM, Wang ZC, Brock JE and Richardson AL:
Retraction notice to: A pleiotropically acting MicroRNA, miR-31,
inhibits breast cancer metastasis. Cell. 161:4172015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Iorio MV and Croce CM: MicroRNA
dysregulation in cancer: Diagnostics, monitoring and therapeutics.
A comprehensive review. EMBO Mol Med. 4:143–159. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bian K, Fan J, Zhang X, Yang XW, Zhu HY,
Wang L, Sun JY, Meng YL, Cui PC, Cheng SY, et al: MicroRNA-203
leads to G1 phase cell cycle arrest in laryngeal carcinoma cells by
directly targeting survivin. FEBS Lett. 586:804–809. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tian Y, Fu S, Qiu GB, Xu ZM, Liu N, Zhang
XW, Chen S, Wang Y, Sun KL and Fu WN: MicroRNA-27a promotes
proliferation and suppresses apoptosis by targeting PLK2 in
laryngeal carcinoma. BMC Cancer. 14:6782014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ying X, Kai W, Wei G, Zhang C, Huang F,
Wen S and Wang B: MicroRNA-106b regulates the tumor suppressor
RUNX3 in laryngeal carcinoma cells. FEBS Lett. 587:3166–3174. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kusunoki S, Kato K, Tabu K, Inagaki T,
Okabe H, Kaneda H, Suga S, Terao Y, Taga T and Takeda S: The
inhibitory effect of salinomycin on the proliferation, migration
and invasion of human endometrial cancer stem-like cells. Gynecol
Oncol. 129:598–605. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang TQ, Lu XJ, Wu TF, Ding DD, Zhao ZH,
Chen GL, Xie XS, Li B, Wei YX, Guo LC, et al: MicroRNA-16 inhibits
glioma cell growth and invasion through suppression of BCL2 and the
nuclear factor-κB1/MMP9 signaling pathway. Cancer Sci. 105:265–271.
2014. View Article : Google Scholar : PubMed/NCBI
|
